Literature DB >> 6192908

Sugar chain of alpha-fetoprotein produced in human yolk sac tumor.

K Yamashita, A Hitoi, Y Tsuchida, S Nishi, A Kobata.   

Abstract

The carbohydrate moiety of alpha-fetoprotein purified from human yolk sac tumors grown in nude mice was quantitatively released from the polypeptide chain as oligosaccharides by hydrazinolysis. The oligosaccharides were separated into a neutral and two acidic oligosaccharides by paper electrophoresis. By sequential exoglycosidase digestion in combination with per-O-methylation study and periodate oxidation, their structures were determined to be: Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(GlcNAc beta 1 leads to 4) (Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc beta 1 leads to 4(Fuc alpha 1 leads to 6)GlcNAcOT, Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(GlcNAc beta 1 leads to 4) (Sia alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc beta 1 leads to 4(Fuc alpha 1 leads to 6)GlcNAcOT; and Sia alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(GlcNAc beta 1 leads to 4) (Sia alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4 GlcNAc beta 1 leads to 4(Fuc alpha 1 leads to 6)GlcNAcOT, in which Gal is galactose, GlcNac is N-acetylglucosamine, Man is mannose, Fuc is fucose, Sia is sialic acid, and Subscript OT is the NaB3H4-reduced oligosaccharide.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192908

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Probing the frontiers of glycoprotein synthesis: the fully elaborated β-subunit of the human follicle-stimulating hormone.

Authors:  Pavel Nagorny; Neeraj Sane; Bernhard Fasching; Baptiste Aussedat; Samuel J Danishefsky
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-09       Impact factor: 15.336

Review 2.  Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.

Authors:  T Itoh; K Kishi; M Tojo; N Kitajima; Y Kinoshita; T Inatome; H Fukuzaki; N Nishiyama; H Tachibana; H Takahashi
Journal:  Gastroenterol Jpn       Date:  1992-12

3.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09

Review 4.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

5.  Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Authors:  S Ho; P Cheng; J Yuen; A Chan; N Leung; W Yeo; T Leung; W Y Lau; A K Li; P J Johnson
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

6.  Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.

Authors:  P J Johnson; T C Poon; N M Hjelm; C S Ho; S K Ho; C Welby; D Stevenson; T Patel; R Parekh; R R Townsend
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

7.  Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.

Authors:  Y Aoyagi; Y Suzuki; K Igarashi; A Saitoh; M Oguro; T Yokota; S Mori; T Suda; M Isemura; H Asakura
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.